Published on in CHOP News
Patients with this complex neurological disorder experience a wide variety of symptoms, which can be managed with early and proper diagnosis.
Published on in CHOP News
STXBP1-related disorders include gastrointestional and respiratory symptoms in certain patients, according to extensive interviews with caregivers.
Published on in CHOP News
A $25 million gift from an anonymous donor to Penn Medicine and Children’s Hospital of Philadelphia (CHOP) will establish the Center for Epilepsy and Neurodevelopmental Disorders (ENDD), accelerating collaborative research in genetic therapies for neurodevelopmental disorders.
Published on in Neurosciences Update
Founded in 2005, the Pediatric Multiple Sclerosis and Neuroinflammatory Disorders Clinic at CHOP is recognized as a Partner in MS Care – Center for Comprehensive Care by the National Multiple Sclerosis Society.
Published on in Neurosciences Update
The Neuroscience Center prioritizes partnered care relationships that maximize expertise, access to novel therapies, and local care.
Published on in CHOP News
Through collaboration with research partners, patients, foundations, and community members, we are working to defeat childhood brain cancer and find better treatments for current patients. Read about recent milestones we’ve hit to accelerate pediatric brain tumor research.
Published on in CHOP News
Two researchers from Children’s Hospital of Philadelphia (CHOP) were recently selected by the health and science news outlet STAT as 2022 Wunderkinds, an award that celebrates the next generation of scientific superstars who are making significant contributions to biomedical research.
Published on in CHOP News
Patients with the identified variant may respond favorably to targeted treatment with a readily available anti-seizure medication.
Published on in CHOP News
Certain patients were more likely to use telemedicine even with the reopening of in-person appointments, while barriers to telemedicine remained for some families.
Published on in CHOP News
CHOP neurosurgeons collaborated with researchers from the University of Pennsylvania School of Medicine to confirm the presence of these neurons from birth through age 92.